Health Awareness Topics - April 2012
New research review, clinician and consumer guides added
! Visit the AHRQ Evidence Reports
page for a listing of reports produced under AHRQ's Evidence-based Practice Program
and Effective Health Care Program
The Guidelines International Network (G-I-N) Conference 2012
, will be held August 22-25, 2012
in Berlin, Germany. Registration
is now open.
U.S. Food and Drug Administration (FDA) Advisory
- April 10, 2012: Birth Control Pills Containing Drospirenone : FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.
NGC's Sister Resources